Business & Finance
Eisai forecasts 73% Leqembi revenue growth in FY 2025, boosting BioArctic royalties
15 May 2025 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) reported on Thursday that its partner Eisai Co Ltd (TYO:4523) projects Leqembi (lecanemab) revenue to reach JPY76.5bn (...
ValiRx subsidiary Inaphaea extends drug repurposing deal with Dominion Biotech
12 May 2025 - ValiRx plc (AIM: VAL), a specialist in early-stage cancer therapeutics and women's health, reported on Monday that it has extended a commercial agreement between its wholly owned su...
Bavarian Nordic secures USD143.6m US government contract for freeze-dried smallpox/mpox vaccine supply
6 May 2025 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Tuesday that the US Biomedical Advanced Research and Development Authority (BARDA) has exercised contract option...
Lilly declares Q2 2025 dividend
6 May 2025 - The board of directors of pharmaceutical company Eli Lilly and Company (NYSE:LLY) on Monday declared a dividend of USD1.50 per share of common stock for the second quarter of 2025.This am...
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
16 April 2025 - Life science research and diagnostics solutions provider Bruker Corporation (Nasdaq:BRKR) announced on Wednesday that it has acquired a majority stake in RECIPE Chemicals + Instruments...
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
15 April 2025 - Commercial-stage biopharmaceutical company Emmaus Life Sciences Inc. (OTCQB:EMMA) on Monday reported net revenues of USD16.7bn for the year ended 31 December 2024, down almost 44% from...